Navigation Links
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Date:9/21/2009

ABBOTT PARK, Ill., Sept. 21 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today it received approval from the U.S. Food and Drug Administration (FDA) for its ABBOTT PRISM HIV O Plus test, the first fully automated blood screening test for HIV-1/HIV-2. This test can be used by laboratory professionals to screen individual donors of blood and plasma for antibodies to human immunodeficiency virus type 1 Groups M and O (anti-HIV-1) and type 2 (anti-HIV-2), and as an aid in the diagnosis of HIV-1/HIV-2 infection.

The assay, which provides laboratories a fully automated test compared to the current method, runs on the ABBOTT PRISM system, which can run 160 samples per hour, making it possible to test more than 1,200 samples in an eight-hour shift. Speed and efficiency are important to labs given the volume of blood that is screened each year. According to the American Association of Blood Banks (AABB), eight million volunteers donate about 15 million units of whole blood each year in the United States alone. Each donated unit of blood must be tested for infectious diseases including hepatitis, HIV and other retroviruses. Abbott's hepatitis and retrovirus tests are used thousands of times every day around the globe for blood screening and diagnostic testing.

With this approval, Abbott now has a complete panel of hepatitis and retrovirus tests on the ABBOTT PRISM system which includes the following assays: a hepatitis B core test (ABBOTT PRISM HBcore); a hepatitis B surface antigen test (ABBOTT PRISM HBsAg along with ABBOTT PRISM HBsAg Confirmatory); a hepatitis C test (ABBOTT PRISM HCV); and a human T- lymphotropic virus test (ABBOTT PRISM HTLV-I/HTLV-II). Used in more than 30 countries, the ABBOTT PRISM is used to screen the majority of the blood supply in the U
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Abbott Announces TCT 2009 Activities
2. Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts
3. Abbott Again Named One of the Best Places to Launch a Career by BusinessWeek
4. Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
5. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
6. Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
7. Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
8. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
9. Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education
10. Abbott to Acquire Nutrition Businesses, Expanding Presence in India
11. Abbott and Medtronic Reach Agreement on Global Patent Disputes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Fish oil ... 2 diabetes, new research suggests. The ... levels of a hormone called adiponectin that,s linked ... of this hormone in the bloodstream have also ... disease. "While prior animal studies found fish ...
(Date:5/22/2013)... at Massachusetts General Hospital (MGH) one of the ... half rated the training they had received in addiction ... Significant numbers felt unprepared to diagnose or treat such ... response to the findings, recently published online in the ... residents, training in addiction medicine. , "Our residents ...
(Date:5/22/2013)... effect does a father,s depression have on his young son ... intimacy in their marriage, their children benefit, said a University ... their child, they need to be able to attend to ... stage and abilities, and notice whether he is getting frustrated ... said Nancy McElwain, a U of I professor of human ...
(Date:5/22/2013)... A new study suggests that disturbed sleep in ... and greater uncertainly about future success. However, ... appears to have a protective effect. , ... with depressed mood and greater uncertainty about future ... and from teachers were associated with significantly fewer ...
(Date:5/22/2013)... "power plants" that make energy to keep cells alive ... of the drug-resistant forms of cancer source of ... conclusion of a new study published in the journal ... and colleagues explain that doxorubicin and other common forms ... nucleus of cancer cells. Cancer cells divide and multiply ...
Breaking Medicine News(10 mins):Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2
... 21 Organogenesis, Inc. announced today that it has filed ... Drug Administration (FDA) for its CelTx(TM), a living cellular construct ... be the first, living cell-based technology that is FDA-approved for ... in the field, Organogenesis is the world,s first regenerative medicine ...
... , NEW YORK, Dec. 21 Today, Equinox ... Pure Yoga, a luminous playground from Hong Kong where many ... Yoga is quite simply that. An aah-inspiring return to the ... modern, minimalist luxury. The result is an accessible and immersive ...
... ... point to a US-led psychological-warfare operation, apparently designed to influence a myriad of factors. ... the world’s media landscape,” says best-selling investigative author Daniel Estulin. , ... Walterville, OR/ Bangkok (Vocus) Dec. 21, ...
... ... Industry. , ... December 21, 2009 -- Nu-Tek Products (nu-tekproducts.com) is meeting the demand for new innovative ... soymilk is fermented with selected Probiotic cultures L. acidophilus, Bifidobacterium lactis. L. bulgaricus and ...
... ... the year. During the dark winter months, sunlight can be an insufficient ... and phosphorous. Low vitamin D levels have recently been linked to a ... and the common cold. , The good news is that there is ...
... ... two QHR management clients to its “Top 100 Hospitals: Best in ... QHR management client since 1982, and Monroe County Hospital (Monroeville, Ala.), ... which specializes in providing hospitals and other healthcare-related businesses with independent ...
Cached Medicine News:Health News:Organogenesis Files PMA for CelTx(TM) for Oral Soft Tissue Regeneration 2Health News:Organogenesis Files PMA for CelTx(TM) for Oral Soft Tissue Regeneration 3Health News:Equinox Introduces its Second Pure Yoga Studio on the Upper West Side 2Health News:Equinox Introduces its Second Pure Yoga Studio on the Upper West Side 3Health News:Author Says Thailand Arms Plane Aimed at Swaying Victor Bout's Extradition 2Health News:Shortest Day of the Year: Vitamin D - How to Get It When The Sun Goes Down 2Health News:QHR Hospital Clients Fort Madison Community Hospital, Monroe County Hospital Named to “Best in Value” Top 100 List 2
(Date:5/22/2013)... , May 22, 2013 Ranbaxy Laboratories ... Co., Ltd. (hereafter, Daiichi Sankyo), announced on May ... recent years to address past conduct under prior ... Daiichi Sankyo continues to support Ranbaxy ... conduct of the past which led to the ...
(Date:5/22/2013)... 22. Mai 2013  Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
(Date:5/22/2013)... and REHOVOT, Israel , May 22, ... ), a leading developer and provider of microRNA-based molecular ... , President and Chief Executive Officer of Rosetta Genomics, ... Healthcare Conference taking place from June 3-6, 2013 in ... on Tuesday, June 4 th at 2:00 p.m. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
... N.J., Jan. 4, 2012   CANTEL MEDICAL CORP. ... CEO, will be presenting at the Needham & Company, ... scheduled for 9:20 AM ET on Wednesday, January 11, ... Q & A session immediately following the presentation. In ...
... marketers who need to calibrate multi-channel marketing and sales ... SyntheSight™ , a new proprietary pharmaceutical ... patent-pending IntelliScore™ , provides actionable insights ... answers. SyntheSight ...
Cached Medicine Technology:RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 2RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: